Judge rejects Allergan challenge to FCA suit

A California judge has allowed a patent attorney to proceed with his claims against Allergan which allege the pharmaceutical company fraudulently obtained patents to monopolise pricing.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Fed Circuit remands Allergan inventorship dispute

11 November 2020 The US Court of Appeals for the Federal Circuit concluded that a New York judge had rushed to grant summary judgment in an inventorship dispute between Ferring and Allergan.

Big Pharma

FTC demands AbbVie divests Crohn’s treatment in Allergan buyout

7 September 2020 The US Federal Trade Commission has approved a final order regarding charges that biopharmaceutical company AbbVie’s $63 billion acquisition of Allergan would violate US federal antitrust law.

Americas

Lawyer opposes Allergan’s bid for interlocutory appeal in FCA suit

18 January 2021 Allergan should not be permitted to immediately appeal against a recent ruling which requires it to face allegations that it monopolised the pricing of dementia drugs, according to a New York-based patent attorney.

More on this story

Big Pharma

Fed Circuit remands Allergan inventorship dispute

11 November 2020 The US Court of Appeals for the Federal Circuit concluded that a New York judge had rushed to grant summary judgment in an inventorship dispute between Ferring and Allergan.

Big Pharma

FTC demands AbbVie divests Crohn’s treatment in Allergan buyout

Americas

Lawyer opposes Allergan’s bid for interlocutory appeal in FCA suit

More on this story

Big Pharma

Fed Circuit remands Allergan inventorship dispute

11 November 2020 The US Court of Appeals for the Federal Circuit concluded that a New York judge had rushed to grant summary judgment in an inventorship dispute between Ferring and Allergan.

Big Pharma

FTC demands AbbVie divests Crohn’s treatment in Allergan buyout

Americas

Lawyer opposes Allergan’s bid for interlocutory appeal in FCA suit